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Identification and functional analysis of the ezrin-binding site in
the hyaluronan receptor, CD44
James W. Legg and Clare M. Isacke
ERM (ezrin, radixin and moesin) proteins function as
linkers between the actin cytoskeleton and the plasma
membrane (reviewed in [1–3]). In addition to this
structural role, these proteins are highly regulatable
making them ideal candidates to mediate important
physiological events such as adhesion and membrane
morphology [4–7] and to control formation and
breakdown of membrane–cytoskeletal junctions [8–15].
Recently, a direct interaction in vitro [8,16] has been
demonstrated between ERM proteins and the
hyaluronan receptor, CD44 (reviewed in [17]). We have
mapped the ezrin-binding site to two clusters of basic
amino acids in a membrane-proximal 9 amino-acid
region within the CD44 cytoplasmic domain. To
investigate the functional importance of this interaction
in vivo, we created a number of mutations within full-
length CD44 and expressed these mutants in human
melanoma cells. We demonstrate here that mutations
within the ezrin-binding site do not disrupt the plasma
membrane localization of CD44 and, in addition, that
this region is not required to mediate efficient
hyaluronan binding. These studies suggest that ERM
proteins mediate the outside–in, rather than inside–out,
signalling of adhesion receptors.
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Results and discussion
Mapping of the ezrin-binding site within the cytoplasmic
domain of CD44
An in vitro ‘pulldown’ assay was used to study the inter-
action between ezrin and fusion proteins of the CD44
cytoplasmic domain with glutathione-S-transferase
(GST). GST–CD44, but not GST alone, associated with
an 81 kDa protein from Madin–Darby canine kidney
(MDCK; Figure 1a), Swiss 3T3 fibroblast, human RPM-
MC melanoma and human SW620 colonic carcinoma
cells (data not shown) which reacted with the anti-ezrin
antibody and co-migrated with an ezrin band detected in
cell lysates (Figure 1a). In order to map the ezrin-binding
site in CD44, a series of large GST–CD44 deletion
mutants were generated. Pulldown assays demonstrated
that the mid (residues 316–345) and carboxy-terminal
(residues 337–361) domains of the CD44 cytoplasmic tail
were not required for ezrin binding but that deletion of
the amino-terminal domain (residues 296–315) com-
pletely abolished the association with ezrin (Figure 1a).
Smaller deletions within this membrane-proximal
domain revealed that loss of residues 289–291, 301–305,
306–310 and 311–316 did not affect binding, but that
deletion of either residues 289–295 or 296–300 resulted
in a complete loss of associated ezrin (Figure 1b). This
membrane-proximal ezrin-binding site is completely con-
served between species (reviewed in [18]) and is found in
all of the alternatively spliced CD44 isoforms (reviewed
in [17]). In addition, it is spatially removed from the prin-
cipal site of CD44 phosphorylation at Ser325 [19,20].
Together with the demonstration that nonphosphory-
lated bacterially expressed GST–CD44 constructs retain
the ability to associate with ezrin, this suggests that phos-
phorylation of CD44 does not regulate ezrin binding.
To further characterize the ezrin-binding site, extensive
mutagenesis was undertaken across R292RRCGQKKK300
(in the single-letter amino-acid code). Mutation of the
K298KK300 residues resulted in impaired ezrin binding,
with Ala298, Ala299/Ala300 and Gln298/Ile299/Asn300
mutants binding at 67%, 39% and < 5%, respectively, of
levels bound by the wild-type CD44 cytoplasmic domain
(Figure 1c). A similar binding profile was also observed for
radixin (data not shown). Recently, Yonemura et al. [21]
also demonstrated a requirement for K298KK300 in CD44,
and similar triads of basic amino acids in ICAM-2 and
CD43, in the interaction with ERM proteins. In contrast
to these studies, we also demonstrate here that mutations
within a second cluster of basic residues, R292RR294,
severely impair ERM binding, as the Ala292/Ala293
mutant bound undetectable levels of ezrin. Mutation of
G296Q297 to alanines, however, resulted in a mutant which
bound ezrin at 108% of wild-type levels while an
Ala294/Ala295 mutant bound with an efficiency of 87%. It
remains to be determined whether additional residues
within ICAM and CD43 are also required for efficient
ERM binding. Alternatively, the presence of a second
domain within the ERM-binding site, or the spacing of
these domains, might be unique to CD44 and thereby
function to generate binding specificity between the
ERM proteins and their transmembrane partners.
Mutation of the CD44 ezrin-binding site does not impair
hyaluronan binding or disrupt CD44 distribution
To investigate the role of ERM binding on CD44 function,
we expressed full-length wild-type and ERM-binding-
deficient CD44 receptors in a CD44-negative RPM-MC
human melanoma cell line. For these studies, the critical
basic clusters within the ERM-binding site were mutated
individually or in combination. In all cases, these mutations
had no detectable effect on CD44 post-translational pro-
cessing, as expressed proteins co-migrated with wild-type
CD44 with a molecular mass of approximately 85 kDa
(data not shown). It is well established that truncation of
the CD44 cytoplasmic domain severely impairs hyaluronan
binding [22–24]. Given that ERMs are cytoskeletally asso-
ciated proteins, their interaction with CD44 might be
expected to mediate efficient ligand binding by stabilizing
the receptor in a hyaluronan-binding conformation. An
investigation of this revealed that clonal lines expressing a
severe ERM-binding mutant (CD44∆296–300) or a partial
ERM-binding mutant (CD44-Ala298) displayed fluores-
cein isothiocyanate (FITC)-conjugated hyaluronan
binding equivalent to wild-type CD44 (Figure 2). Further
analysis of RPM-MC cells expressing CD44-
Ala292/Ala293/Ala294, CD44-Gln298/Ile299/Asn300 and
CD44-Ala293/Ala294/Ala298/Ala299/Ala300 similarly rev-
ealed no reduction in hyaluronan binding (data not shown).
These data are in agreement with those of Perschl et al.
[22], who proposed a model in which the stabilization of
hyaluronan binding requires a minimal cytoplasmic domain
region that is not dependent upon a specific amino acid
sequence, rather than a model in which domains of the
cytoplasmic tail regulate binding via association with
cytoskeletal components.
In order to investigate whether an interaction with ERM
proteins directs CD44 distribution in the plasma mem-
brane, transfected cells were examined by confocal
microscopy. In these cells, ezrin is closely associated with
the plasma membrane in sites of cell–cell contact, ruffling
edges, membrane projections and microvilli and there is a
marked co-localization with CD44 (Figure 3a,b). This dis-
tribution of ezrin is not mediated by its association with
CD44, as in CD44-negative cells or cells expressing ERM-
binding mutants, ezrin was observed clearly localized in
the microvilli (Figure 3c–h) and other sites at which actin
microfilaments closely associate with the plasma mem-
brane (data not shown). This supports the evidence of
Algrain et al. [25] that ezrin localization is predominantly
regulated by its association with cytoskeletal components.
In addition, mutation of the basic clusters, individually or
in combination, had no effect on CD44 localization to
membrane projections or ruffles (data not shown).
Recently, it has been reported that an E-cadherin–CD44
chimaera containing a Gln298/Ile299/Asn300 ERM-
binding mutation is impaired in its ability to localize to the
microvilli [21]. Here, we have examined the microvillal
localization of deletion and alanine-substitution mutant
proteins and an equivalent Gln298/Ile299/Asn300 mutation
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Figure 1
Mapping of the ezrin-binding site in CD44.
Deletion and point mutations were generated
by PCR using the high-fidelity Pfu polymerase
(Stratagene). Wild-type CD44 cytoplasmic
domain (residues 289–361) or cytoplasmic-
domain mutants were ligated into the pGEX-
KG vector, transformed into BL21(DE3)pLysS
bacteria, and GST fusion proteins isolated on
glutathione–agarose beads. For pulldown
assays, MDCK cells were lysed in 10 mM
HEPES pH 7.5, 1 mM MgCl2, 40 mM KCl, 1%
Triton X-100, 1 mM PMSF for 15 min, cleared
by centrifugation and incubated with fusion
protein–glutathione–agarose beads for 1 h.
Fusion proteins were eluted in nonreducing
gel-loading buffer, resolved by SDS–PAGE,
transferred onto nitrocellulose and probed
with an anti-ezrin antibody [14] followed by
horseradish-peroxidase-conjugated anti-rabbit
immunoglobulin (Jackson Immunoresearch)
and visualized by enhanced chemi-
luminescence. Left-hand panels show fusion
constructs; right-hand panels show ezrin
pulldown assays. Parallel gels were stained
with Coomassie blue. Blots and gels were
densitometrically scanned to quantitate
relative levels of ezrin and GST fusion
proteins. Molecular weights are in kDa. Lys in
(a) represents 5 µl of MDCK cell lysate.
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generated in the full-length CD44 receptor. In all cases,
CD44 mutant proteins were observed clearly co-localized
with ezrin in the microvilli (Figure 3d–g).
Our data would imply that although CD44 and ERM pro-
teins can associate, neither plays a primary role in deter-
mining the localization of the other. Furthermore, these
studies demonstrate that expression of CD44 in RPM-MC
melanoma cells is not required for microvillus formation.
It remains to be determined whether there is a role for
transmembrane receptor–ERM interactions in defining
the biogenesis/structure of microvilli and if so whether
other ERM-binding proteins substitute for CD44 in
CD44-negative cells. It is not known why the co-localisa-
tion studies shown in Figure 3 contradict those obtained
by Yonemura et al. [21], but these differences may result
from the use of full-length functional CD44, which can
bind hyaluronan, as opposed to chimeric CD44 constructs
lacking the CD44 extracellular domain. Alternatively, dif-
ferences may reflect cell-type-specific events such that
mutant CD44 distribution may be differentially regulated
in the CD44-negative RPM-MC cells and the L cells
which contain endogenous murine CD44. It should be
noted that although the two co-localization experiments
were performed with ezrin and moesin respectively, both
studies employed the CD44-Gln298/Ile299/Asn300 muta-
tion, which is unable to bind either ERM protein. In con-
trast to the ERM-binding mutants, a CD44 construct
truncated at Cys295 (tailless CD44) failed to localize to
the microvilli (Figure 3h), suggesting that there is an alter-
native, or additional, requirement outside the ERM-
binding site for plasma membrane localization. In CD44, a
di-hydrophobic motif at Leu331/Val332 has been identi-
fied as a polarized epithelial cell basolateral localization
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Figure 2
CD44 containing mutations within the ERM-binding site bind
hyaluronan with high efficiency. Mutations in full-length CD44 in the
pSRα–neo eukaryotic expression vector were generated by PCR
mutagenesis and transfected into the CD44-negative RPM-MC
melanoma cell line as previously described [29]. Clonal RPM-MC lines
were labelled with FITC-conjugated hyaluronan (FITC–HA), and CD44
was labelled with the monoclonal antibody E1/2 followed by
biotinylated anti-mouse immunoglobulin and R-phycoerythrin avidin
(CD44–PE) and analysed by two-colour flow cytometry [22,23]. The
mean FITC–HA fluorescence was calculated over channel intervals of
phycoerythrin fluorescence. With cells transfected with vector alone,
more than 95% had anti-CD44–PE and anti-FITC–HA labelling of less
than 100. Independent clonal lines are denoted a and b.
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Figure 3
Distribution of CD44 and ezrin. Bulk populations of G418-resistant
RPM-MC cells transfected with wild-type or mutant CD44 were fixed
in 3% paraformaldehyde, permeabilized with 0.2% saponin and
stained with anti-CD44 monoclonal antibody E1/2 followed by
FITC–anti-mouse immunoglobulin and anti-ezrin antisera followed by
Texas red–anti-rabbit immunoglobulin and viewed by confocal
microscopy. Scale bar = 25 µm. (a,b) Wild-type CD44;
(c) pSRα–neo vector alone; (d) CD44∆296–300; (e) CD44-
Ala292/Ala293/Ala294; (f) CD44-Gln298/Ile299/Asn300;
(g) CD44-Ala293/Ala294/Ala298/Ala299/Ala300; (h) tailless CD44.
(a)
CD44 Ezrin CD44 Ezrin
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(b)
(c) (d)
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motif [26]. It is not known, however, whether this has a
role in regulating CD44 distribution in nonpolarized cells.
Potentially more significant is the close proximity of the
ERM-binding site to the transmembrane domain. The
transmembrane domain is responsible for the observed
CD44 Triton X-100 insolubility due to its ability to inter-
act with glycolipid-enriched microdomains [27,28]. One
major function of glycolipid-enriched microdomains is to
cluster key components of signal transduction pathways. It
is tempting, therefore, to speculate that an association of
ERM proteins at a site close to the CD44 transmembrane
domain may function to regulate its subsequent interac-
tions with downstream signalling pathways. In conclusion,
the data presented here would suggest that ERM proteins
are not key mediators of inside–out transmembrane recep-
tor signalling, rather they are more probably candidates as
regulators of outside–in signalling events.
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